Molly Ann Poucher, APRN

Molly Poucher practices at Project Health, Inc. in Sumterville, Florida.

Molly Poucher's NPI, 1154006948, was assigned on June 19, 2023. Molly Poucher holds Florida license 11027022.

Molly Poucher's primary practice is Project Health, Inc., at 1425 S Us 301, Sumterville, FL 33585 in Sumter County. The practice phone is (352) 793-5900.

Molly Poucher's primary practice is Project Health, Inc. in Sumterville, Florida. The medical group on file is Langley Health Services. Dmand AI also links Molly Poucher to 3 more medical groups, each named with a free account. Molly Poucher's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Molly Poucher practices. Vendor and product names are available with a free account.

Nurse practitioner is Molly Poucher's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Molly Poucher is licensed in Florida.

Dmand AI lists chronic diabetes and mobility impairment among the conditions Molly Poucher treats.

CMS data shows 732 Medicare services from Molly Poucher across 4 procedure codes in 2024, for 101 Medicare patients. Medicare paid $82,387 for them.

CMS counts 101 Medicare patients who saw Molly Poucher in 2024. The largest group is 85 and over, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 3.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Molly Poucher's median patient age at 57, with 64% women.

In 2024, Molly Poucher wrote 150 Medicare Part D claims for 52 patients. 89% of them were for generic drugs. CMS names the drug for 112 of them, across 7 drugs with 11 or more claims each, at $25,680 in total drug cost.

Molly Poucher accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 39 general payments to Molly Poucher from 16 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 60% of the total. Smith & Nephew, Inc. paid the most, $1,394.